Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence, Recommendations, and Ethical Issues Regarding Dual HER...

por Ahn, Eugene R., Wang, Emilie, Glück, Stefan
Publicado 2012

Integrative Oncology and the Clinical Care Network: Challenges and Opportunities

por Semeniuk, George, Bahadini, Bahareh, Ahn, Eugene, Zain, Jasmine, Cheng, Jessica, Govindarajan, Ameish, Rose, Judy, Lee, Richard T.
Publicado 2023

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients

por Baeg, Kiwoon, Harris, Cynthia, Naparst, Monica S., Ahn, Eugene, Thapi, Sahityasri, Martin, Jacob, Rustgi, Sheila, Mhango, Grace, Wisnivesky, Juan, Kim, Michelle Kang
Publicado 2021

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

por Zeichner, Simon B, Ambros, Tadeu, Zaravinos, John, Montero, Alberto J, Mahtani, Reshma L, Ahn, Eugene R, Mani, Aruna, Markward, Nathan J, Vogel, Charles L
Publicado 2015